AKT1 and central nervous system cancer: Blum et al. demonstrated that pharmacological inhibition of Ras in glioma cells caused a reduction in HIF-1α expression via inhibition of the PI3K/AKT pathway and in turn decreases of PFKFB3 and glycolysis, promoting cell death [202].